The Pancreas
Rodger trained in the laboratory of renowned pancreatic physiologist, John A. Williams, at the University of California, San Francisco. There, using isolated pancreatic acini, he developed the world’s first reliable bioassay for measuring blood levels of the gastrointestinal hormone, cholecystokinin (CCK), a major pancreatic secretagogue. His laboratory has continued to explore novel mechanisms regulating pancreatic function, including pathways involved in pancreatitis. His laboratory described the neurogenic processes that contribute to the initiation, progression and severity of acute pancreatitis. He also characterized endogenous trypsin inhibitors that serve as a protection against pancreatitis.
Recently, his laboratory discovered that the pancreas senses pressure through the mechanically activated ion channel Piezo1. High pressure causes acute pancreatitis through Piezo1 activation in acinar cells and prolonged pressure activates Piezo1 in stellate cells and produces pancreatic fibrosis. Finally, his laboratory made the unique observation that acute pancreatitis was associated with hypophosphatemia and phosphate treatment reduces pancreatitis severity. These studies hold promise for developing a therapy for human pancreatitis.
Piezo1 in mouse pancreas. Piezo1 is a mechanically activated ion channel and mediates pressure-induced pancreatitis (Nature Communications, 2018).
Piezo1 agonist Yoda1, induced intracellular calcium elevation in pancreatic acini.
Pancreatitis in a dish: the Piezo1 agonist, Yoda1, induces basolateral zymogen release in pancreatic acini.
TRVP4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation (Journal of Clinical Investigation, 2020).
Piezo1 agonist, Yoda1, activates pancreatic stellate cells. Note the loss of perinuclear fat droplets and increased fibronectin.
Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice (Journal of Clinical Investigation, 2022).